Ezetimibe-induced acute pancreatitis.
Ezetimibe is a lipid-lowering agent that inhibits the intestinal absorption of cholesterol and other related phytosterols. It is used alone or in combination with other lipid-lowering agents in the treatment of various forms of hypercholesterolemia. Since its FDA approval in 2002, there are no known citations of ezetimibe-induced pancreatitis.
Ahmad
Imran
I
Mercy Fitzgerald Hospital, Darby, PA, USA. iahmadmd@yahoo.com
Ruby
Edward
E
Usman
Harris
H
Hotiana
Mateen
M
Hussain
Mehnaz
M
Rahman
Fahd
F
D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D050171:Dyslipidemias / Q000188:drug therapy; D000069438:Ezetimibe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008049:Lipase / Q000097:blood; D008875:Middle Aged; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000175:diagnosis / Q000201:enzymology
D000924:Anticholesteremic Agents; D001384:Azetidines; D008049:Lipase; D000069438:Ezetimibe